Physician
Sachin Kumar Amruthlal Jain Cardiovascular P.C.
Sachin Kumar Amruthlal Jain Cardiovascular P.C. was paid $12.66M by Medicaid between Mar 2019 and Dec 2024, across 34 billing codes. Its largest line is 36475, — 21% of everything it billed.
33Billing provider infoSACHIN KUMAR AMRUTHLAL JAIN CARDIOVASCULAR P.C.
YONKERS, NY 10701
YONKERS, NY 10701
33aNPI1073003190assigned 05/14/2018
33bProvider typeCardiovascular Disease Physician
28Total paid$12.66M
24GClaims77,582
24DCodes billed34
24AFirst – last monthMar 2019 – Dec 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in New York
Rank by total paid#3 of 1,564
Median peer was paid$13K
This provider vs. median973×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 730 | $70K | |
| 2020 | 8,487 | $2.08M | |
| 2021 | 11,552 | $2.29M | |
| 2022 | 15,821 | $2.61M | |
| 2023 | 20,182 | $2.89M | |
| 2024incomplete | 20,810 | $2.72M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36475 | 21% | 2,056 | 1,098 | $2.62M | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 26,284 | 19,601 | $2.02M |
| 36465 | 14% | 1,401 | 911 | $1.82M | |
| 93970 | 9.4% | 7,194 | 7,138 | $1.18M | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 7.9% | 5,455 | 5,440 | $996K |
| 36478 | 4.3% | 652 | 408 | $544K | |
| 93922 | 4.1% | 6,489 | 6,394 | $517K | |
| 93880 | 3.8% | 2,996 | 2,984 | $485K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.6% | 2,995 | 2,988 | $455K |
| 93925 | 3.3% | 2,154 | 2,136 | $421K | |
| 93971 | 3.2% | 3,760 | 2,353 | $407K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1.9% | 704 | 704 | $241K |
22 more codes
| 93241 | 1.7% | 777 | $216K | |
| 93229 | 1.5% | 280 | $185K | |
| 93924 | <1% | 816 | $118K | |
| 93000 | <1% | 9,438 | $115K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 613 | $96K |
| 93975 | <1% | 370 | $82K | |
| 93015 | <1% | 708 | $40K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 241 | $27K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 698 | $15K |
| 93926 | <1% | 147 | $13K | |
| 93978 | <1% | 76 | $9K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 677 | $8K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 242 | $6K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 13 | $5K |
| 99457 | <1% | 106 | $5K | |
| 78013 | <1% | 41 | $5K | |
| 93351 | <1% | 25 | $4K | |
| 93228 | <1% | 119 | $3K | |
| 95923 | <1% | 15 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 16 | $1K |
| 93320 | <1% | 12 | $661.50 | |
| 93325 | <1% | 12 | $324.33 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAMRUTHLAL JAIN, SACHIN KUMAR (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Jain Medical PC | Yonkers, NY | $11K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.